BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Verquvo (Vericiguat) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Verquvo (Vericiguat)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07697833-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20270515
DTEND;VALUE=DATE:20270516
SUMMARY:Verquvo (Vericiguat): Phase 4 readout est. (NCT07697833)
DESCRIPTION:Verquvo (Vericiguat)\, phase 4\, Heart Failure.\nStudy: Compari
 ng the Efficacy and Safety of Vericiguat With Standard Medical Treatment i
 n Heart Failure Patients\nEstimated primary completion: 15 May 2027. This 
 is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it c
 an move.\nDrug page: https://assetmemo.bio/drug/vericiguat#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07697833
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07405944-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Verquvo (Vericiguat): Phase 4 readout est. (NCT07405944)
DESCRIPTION:Verquvo (Vericiguat)\, phase 4\, Heart Failure.\nStudy: Vericig
 uat and Reverse Remodeling Indices in Heart Failure\nEstimated primary com
 pletion: 31 July 2027. This is a ClinicalTrials.gov estimate\, not a confi
 rmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dru
 g/vericiguat#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT07405944
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06239974-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:Verquvo (Vericiguat): Phase na readout est. (NCT06239974)
DESCRIPTION:Verquvo (Vericiguat)\, phase na.\nStudy: Vericiguat in Patients
  With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)
 \nEstimated primary completion: 31 August 2027. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/vericiguat#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT06239974
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06320951-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:Verquvo (Vericiguat): Phase 2 readout est. (NCT06320951)
DESCRIPTION:Verquvo (Vericiguat)\, phase 2.\nStudy: VITAL-IMPACT: Improving
  Cardiometabolic Health in Black Individuals Through Therapeutic Augmentat
 ion of Cyclic Guanosine Mono-Phosphate Signaling Pathway\nEstimated primar
 y completion: 30 April 2028. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/vericiguat#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT06320951
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07668739-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:Verquvo (Vericiguat): Phase 4 readout est. (NCT07668739)
DESCRIPTION:Verquvo (Vericiguat)\, phase 4.\nStudy: Efficacy of Verciguat i
 n TR and RV Failure\nEstimated primary completion: 31 May 2028. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/vericiguat#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07668739
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05812755-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20280731
DTEND;VALUE=DATE:20280801
SUMMARY:Verquvo (Vericiguat): Phase 4 readout est. (NCT05812755)
DESCRIPTION:Verquvo (Vericiguat)\, phase 4.\nStudy: SGC Stimulation\, Perio
 perative Vascular Reactivity\, and Organ Injury in Cardiac Surgery\nEstima
 ted primary completion: July 2028. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/vericiguat#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT05812755
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06601465-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20280716
DTEND;VALUE=DATE:20280717
SUMMARY:Verquvo (Vericiguat): Phase 2 readout est. (NCT06601465)
DESCRIPTION:Verquvo (Vericiguat)\, phase 2\, Heart Failure.\nStudy: COgniti
 oN With VERiciGuat Evaluation in Heart Failure\nEstimated primary completi
 on: 16 July 2028. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ver
 iciguat#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT06601465
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05806138-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20280717
DTEND;VALUE=DATE:20280718
SUMMARY:Verquvo (Vericiguat): Phase 2 readout est. (NCT05806138)
DESCRIPTION:Verquvo (Vericiguat)\, phase 2.\nStudy: A Study of Vericiguat i
 n People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction
 \nEstimated primary completion: 17 July 2028. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/vericiguat#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT05806138
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07594509-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Verquvo (Vericiguat): Phase na readout est. (NCT07594509)
DESCRIPTION:Verquvo (Vericiguat)\, phase na.\nStudy: Perioperative Vericigu
 at in Patients Undergoing Cardiovascular Surgery\nEstimated primary comple
 tion: 31 December 2028. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/vericiguat#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07594509
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05714085-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20290820
DTEND;VALUE=DATE:20290821
SUMMARY:Verquvo (Vericiguat): Phase 2/3 readout est. (NCT05714085)
DESCRIPTION:Verquvo (Vericiguat)\, phase 2/3\, Heart Failure.\nStudy: Effic
 acy\, Safety\, and Pharmacokinetics of Vericiguat in Pediatric Participant
 s With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242
 -036)\nEstimated primary completion: 20 August 2029. This is a ClinicalTri
 als.gov estimate\, not a confirmed readout date\, and it can move.\nDrug p
 age: https://assetmemo.bio/drug/vericiguat#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT05714085
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07715279-587@assetmemo.bio
DTSTAMP:20261121T005639Z
DTSTART;VALUE=DATE:20291031
DTEND;VALUE=DATE:20291101
SUMMARY:Verquvo (Vericiguat): Phase 2 readout est. (NCT07715279)
DESCRIPTION:Verquvo (Vericiguat)\, phase 2.\nStudy: Vericiguat for the Inhi
 bition of Calcific Aortic Valve Stenosis Progression\nEstimated primary co
 mpletion: 31 October 2029. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/vericiguat#upcoming-events\nRegistry record: https://clinicaltrials.
 gov/study/NCT07715279
URL:https://assetmemo.bio/drug/vericiguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
